Literature DB >> 15645265

Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases.

Dennis W Dickson1.   

Abstract

Modern neuropathologic methods and molecular biology have lead to increased understanding of neurodegenerative disorders and biologically based classifications of these disorders. The purpose of this review is to discuss neuropathologic methods that are useful in the characterization of neurodegenerative disorders, with emphasis on disorders of late life that present with dementia or movement disorders. A diagnostic algorithm is suggested for neuropathologic evaluation of neurodegenerative disorders. The importance of clinical information is emphasized in arriving at the most precise and meaningful neuropathologic diagnosis.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15645265     DOI： 10.1007/s00401-004-0950-z

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


  28 in total

1.  Prevalence of Submandibular Gland Synucleinopathy in Parkinson's Disease, Dementia with Lewy Bodies and other Lewy Body Disorders.

Authors:  Thomas G Beach; Charles H Adler; Geidy Serrano; Lucia I Sue; D G Walker; Brittany N Dugger; Holly A Shill; Erika Driver-Dunckley; John N Caviness; Anthony Intorcia; Jessica Filon; Sarah Scott; Angelica Garcia; Brittany Hoffman; Christine M Belden; Kathryn J Davis; Marwan N Sabbagh
Journal:  J Parkinsons Dis       Date:  2016       Impact factor: 5.568

2.  Neuropathological findings of PSP in the elderly without clinical PSP: possible incidental PSP?

Authors:  Virgilio Gerald H Evidente; Charles H Adler; Marwan N Sabbagh; Donald J Connor; Joseph G Hentz; John N Caviness; Lucia I Sue; Thomas G Beach
Journal:  Parkinsonism Relat Disord       Date:  2011-03-21       Impact factor: 4.891

Review 3.  Neuropathological investigation of dementia: a guide for neurologists.

Authors:  S Love
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

4.  The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus.

Authors:  Jeroen J M Hoozemans; Elise S van Haastert; Diana A T Nijholt; Annemieke J M Rozemuller; Piet Eikelenboom; Wiep Scheper
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

5.  Concomitant pathologies among a spectrum of parkinsonian disorders.

Authors:  Brittany N Dugger; Charles H Adler; Holly A Shill; John Caviness; Sandra Jacobson; Erika Driver-Dunckley; Thomas G Beach
Journal:  Parkinsonism Relat Disord       Date:  2014-02-22       Impact factor: 4.891

6.  Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia?

Authors:  Sun-Ah Choi; Virgilio Gerald Hilario Evidente; John N Caviness; Holly A Shill; Marwan N Sabbagh; Donald J Connor; Joseph G Hentz; Charles H Adler; Thomas G Beach
Journal:  Acta Neuropathol       Date:  2009-12-03       Impact factor: 17.088

Review 7.  Essential tremor followed by progressive supranuclear palsy: postmortem reports of 11 patients.

Authors:  Elan D Louis; Rachel Babij; Karen Ma; Etty Cortés; Jean-Paul G Vonsattel
Journal:  J Neuropathol Exp Neurol       Date:  2013-01       Impact factor: 3.685

8.  Submandibular gland biopsy for the diagnosis of Parkinson disease.

Authors:  Thomas G Beach; Charles H Adler; Brittany N Dugger; Geidy Serrano; Jose Hidalgo; Jonette Henry-Watson; Holly A Shill; Lucia I Sue; Marwan N Sabbagh; Haruhiko Akiyama
Journal:  J Neuropathol Exp Neurol       Date:  2013-02       Impact factor: 3.685

9.  Evaluation of subcortical pathology and clinical correlations in FTLD-U subtypes.

Authors:  Keith A Josephs; Alex Stroh; Brittany Dugger; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2009-05-20       Impact factor: 17.088

10.  Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

Authors:  Alex E Roher; Chera L Maarouf; Lucia I Sue; Yiran Hu; Jeffrey Wilson; Thomas G Beach
Journal:  Biomarkers       Date:  2009-11       Impact factor: 2.658
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.